Log in to save to my catalogue

Inhibition of a novel fibrogenic factor Tl1a reverses established colonic fibrosis

Inhibition of a novel fibrogenic factor Tl1a reverses established colonic fibrosis

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4205266

Inhibition of a novel fibrogenic factor Tl1a reverses established colonic fibrosis

About this item

Full title

Inhibition of a novel fibrogenic factor Tl1a reverses established colonic fibrosis

Publisher

New York: Nature Publishing Group US

Journal title

Mucosal immunology, 2014-11, Vol.7 (6), p.1492-1503

Language

English

Formats

Publication information

Publisher

New York: Nature Publishing Group US

More information

Scope and Contents

Contents

Intestinal fibrostenosis is among the hallmarks of severe Crohn’s disease. Patients with certain
TNFSF15
(gene name for TL1A) variants over-express TL1A and have a higher risk of developing strictures in the small intestine. In addition, sustained Tl1a expression in mice leads to small and large intestinal fibrostenosis under colitogenic cond...

Alternative Titles

Full title

Inhibition of a novel fibrogenic factor Tl1a reverses established colonic fibrosis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4205266

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4205266

Other Identifiers

ISSN

1933-0219

E-ISSN

1935-3456

DOI

10.1038/mi.2014.37

How to access this item